OLFM4 and gastric cancer: In GC, the clinicopathological relevance of OLFM4 expression has been reported to be involved not only in early stages of GC but also as a useful prognostic marker for advanced GC, which is encouraging for further studies exploring OLFM4 as a potential target for GC therapy or tracking [79].